Glycogen storage disease types 1 and 2: recent developments, management and outcome G. Peter A. SmitJohn FernandesKurt Ullrich Preface 02 May 2014 Pages: S1 - S1
Historical highlights and unsolved problems in glycogen storage disease type 1 Shimon W. Moses Original Paper 02 May 2014 Pages: S2 - S9
Glycogen storage disease type I: diagnosis and phenotype/genotype correlation Dietrich MaternHans Hermann SeydewitzYuan-Tsong Chen Original Paper 02 May 2014 Pages: S10 - S19
Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I) Jan Peter RakeGepke VisserG. Peter A. Smit Original Paper 02 May 2014 Pages: S20 - S34
Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease David A. WeinsteinJoseph I. Wolfsdord Original Paper 02 May 2014 Pages: S35 - S39
Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence Gerhard DäublinBernd SchwahnUdo Wendel Original Paper 02 May 2014 Pages: S40 - S45
Glycogen storage disease type I: pathophysiology of liver adenomas Philip J Lee Original Paper 02 May 2014 Pages: S46 - S49
The muscle-bone relationship: methods and management—perspectives in glycogen storage disease Eckhard SchönauBernd SchwahnFrank Rauch Original Paper 02 May 2014 Pages: S50 - S52
Glycogen storage disease type I: indications for liver and/or kidney transplantation Philippe Labrune Original Paper 02 May 2014 Pages: S53 - S55
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a Janice Yang ChouAdriana ZingoneChi-Jiunn Pan Original Paper 02 May 2014 Pages: S56 - S61
Is glycogen storage disease 1a associated with atherosclerosis? Froukje L. UbelsJan Peter RakeAndries J. Smit Original Paper 02 May 2014 Pages: S62 - S64
Disturbed lipid metabolism in glycogen storage disease type 1 Robert H. J. BandsmaG. Peter A. SmitFolkert Kuipers Original Paper 02 May 2014 Pages: S65 - S69
Radical trapping in glycogen storage disease 1a Birgit WittensteinMarcus KleinAlfried Kohlschütter Original Paper 02 May 2014 Pages: S70 - S74
Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death Taco W. Kuijpers Original Paper 02 May 2014 Pages: S75 - S82
Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European study on glycogen storage disease type 1 Gepke VisserJan Peter RakeG. Peter A. Smit Original Paper 02 May 2014 Pages: S83 - S87
Association of glycogen storage disease 1b and Crohn disease: results of a North American survey Brian K. DieckgraefeJoshua R. KorzenikLisa Dieruf Original Paper 02 May 2014 Pages: S88 - S92
Severe pulmonary arterial hypertension in type 1 glycogen storage disease Marc HumbertPhilippe LabruneGérald Simonneau Original Paper 02 May 2014 Pages: S93 - S96
Contraception and pregnancy in women affected by glycogen storage diseases Valérie MairovitzPhilippe LabruneRené Frydman Original Paper 02 May 2014 Pages: S97 - S101
More questions: 10 years later from glycogen storage disease patient support groups in Europe Ann Phillips Original Paper 02 May 2014 Pages: S102 - S105
Enzyme therapy for Pompe disease: from science to industrial enterprise Arnold J. J. ReuserHannerieke Van den HoutAns T. Van der Ploeg Original Paper 02 May 2014 Pages: S106 - S111
Guidelines for management of glycogen storage disease type I—European study on glycogen storage disease type I (ESGSD I) Jan Peter RakeGepke VisserG. Peter A. Smit Original paper 02 May 2014 Pages: S112 - S119
Consensus guidelines for management of glycogen storage disease type 1b—European study on glycogen storage disease type 1 Gepke VisserJan Peter RakeG. Peter A. Smit Original Paper 02 May 2014 Pages: S120 - S123
Research in children. A report of the Ethics Working Group of the CESP Pieter J. Sauer Review 27 October 2001 Pages: 1 - 5
Clinical and genetic heterogeneity in congenital hyperinsulinism Thomas MeissnerErtan Mayatepek Review 07 November 2001 Pages: 6 - 20
Immediate allergic reactions after vaccinations – a post-marketing surveillance review Olaf ZentCornelia Arras-ReiterRenald Hennig Original Paper 26 October 2001 Pages: 21 - 25
Glucocorticoid induced impairment of lung structure assessed by digital image analysis Stefan A. TschanzBeat HaenniPeter H. Burri Original Paper 25 October 2001 Pages: 26 - 30
Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant Ryota KakinumaHiroshi ShimizuYunosuke Ogawa Original Paper 09 November 2001 Pages: 31 - 36
Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases Pascale de LonlayJean-Christophe FournetJean-Jacques Robert Original Paper 24 October 2001 Pages: 37 - 48
Aetiological diagnosis of male sex ambiguity: a collaborative study Yves MorelRodolfo ReyNathalie Josso Original Paper 07 November 2001 Pages: 49 - 59
Winner, P., Rothner A. D.: Headache in children and adolescents Susanne Suter Book Review 30 October 2001 Pages: 60 - 60
Massive gastrointestinal bleeding in a 14-year-old boy Masahiko HachiyaChiharu NaraSyuichi Yamada Your Diagnosis 01 November 2001 Pages: 61 - 62
Frequency of glutathione-S-transferase gene deletions in children with neoplasms Elzbieta ZielinskaMalgorzata ZubowskaJerzy Bodalski Research Letter 10 November 2001 Pages: 63 - 64
Pyoderma gangrenosum in childhood - the importance of early recognition Hazel BellRichard Parslew Research Letter 09 October 2001 Pages: 65 - 66
Normal pituitary function in a Japanese patient with Barth syndrome Yuriko KatsushimaIkuma FujiwaraKazuie Iinuma Research Letter 13 November 2001 Pages: 67 - 68
